Is the United States ready for “private techquity”? That’s the name a consulting company gave to the adoption of technology in private equity, including machine learning and data-heavy databases.
Barneys New York and other retailers have struggled in the age of the internet. But what if they had radically changed instead of continuing with business as usual?
Companies are increasingly staying private for longer, raising ever larger amounts from private equity and venture capital. SoftBank Technology Corp.’s Vision Fund took the lead in an $8 billion backing of Uber in January 2018, a little more than a year before the company’s IPO, valuing the business at $48 billion.
Two IPO experts share advice for private equity leaders ahead of going public. They also discuss popular types of IPOs, the trend of direct listings, and why super shares are bad for companies in the long term.
The shifting attitude of regulators has been welcome news for the industry after the roll-out of the Dodd-Frank Act in 2010, the most significant financial law in decades.
There were 1,900 deals in the space last year, according to Connecticut-based publisher Irving Levin Associates in its 2019 report “Seniors Housing & Health Care M&A in the 21st Century.” For buyers, the cool kids on the block were long-term care facilities and physician medical groups, which led the charge for deal-making and consolidation.
Private equity is on the prowl for good deals in the healthcare space right now. There’s a lot of competition and money searching for an investment opportunity. Sometimes, those opportunities involve public companies looking to go private.
Despite headwinds that threatened to throw off healthcare deals, mergers and acquisitions were active in 2019. Even big deals weren’t off the table, despite the uncertainty created by a federal judge’s 2018 decision that the Affordable Care Act was unconstitutional. In fact, some of the biggest deals of early 2019 were in the healthcare space.
In the past few years activists have broadened their horizons, targeting even small and mid cap companies. Institutional investors are supporting activists more and more, and if you didn’t already have enough keeping you up at night, there are two new trends in this ever evolving landscape that put your company at risk.
It’s not a secret that activist hedge funds may not represent the interests of a company’s shareholder base. But a report from Institutional Shareholder Services shows that they don’t look like them, either.